Entrada Therapeutics
TRDA
TRDA
106 hedge funds and large institutions have $210M invested in Entrada Therapeutics in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 23 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
27% less capital invested
Capital invested by funds: $290M → $210M (-$79.8M)
Holders
106
Holding in Top 10
4
Calls
$144K
Puts
–
Top Buyers
| 1 | +$1.5M | |
| 2 | +$1.14M | |
| 3 | +$731K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$651K |
| 5 |
Morgan Stanley
New York
|
+$601K |
Top Sellers
| 1 | -$5M | |
| 2 | -$4.03M | |
| 3 | -$1.14M | |
| 4 |
5VM
5AM Venture Management
San Francisco,
California
|
-$672K |
| 5 |
UBS AM
Chicago,
Illinois
|
-$304K |
